Evoked axonal oxytocin release in the central amygdala attenuates fear response

Neuron

Volumn 73, Issue 3, 2012, Pages 553-566

  Knobloch, H Sophie ^a   Charlet, Alexandre ^b   Hoffmann, LenaC ^a   Eliava, Marina ^a,c   Khrulev, Sergey ^a,d   Cetin, AliH ^a,e   Osten, Pavel ^a,f   Schwarz, MartinK ^a   Seeburg, PeterH ^a   Stoop, Ron ^b   Grinevich, Valery ^a  

^a MAX PLANCK INSTITUTE FOR MEDICAL RESEARCH   (Germany)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

^e SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^f Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXYTOCIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLUE LIGHT; BRAIN NERVE CELL; CENTRAL NUCLEUS (AMYGDALA); CONDITIONING; CONTROLLED STUDY; FEAR; FEMALE; GABAERGIC SYSTEM; HYPOTHALAMUS; IN VITRO STUDY; IN VIVO STUDY; NERVE FIBER; NONHUMAN; OXYTOCIN RELEASE; PRIORITY JOURNAL; RAT;

ACTION POTENTIALS; AMYGDALA; ANALYSIS OF VARIANCE; ANIMALS; AXONS; BEHAVIOR, ANIMAL; CONDITIONING (PSYCHOLOGY); EXCITATORY AMINO ACID ANTAGONISTS; FEAR; FEMALE; FIBER OPTIC TECHNOLOGY; GABA ANTAGONISTS; GENE EXPRESSION REGULATION; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HYPOTHALAMUS; INHIBITION (PSYCHOLOGY); LACTATION; LIGHT; MICROSCOPY, ELECTRON, TRANSMISSION; MODELS, BIOLOGICAL; NEURONS; OXYTOCIN; PATCH-CLAMP TECHNIQUES; PHOSPHOPYRUVATE HYDRATASE; PICROTOXIN; PROSENCEPHALON; QUINOXALINES; RATS; RATS, WISTAR; RHODOPSIN; TIME FACTORS; VASOTOCIN; VESICULAR GLUTAMATE TRANSPORT PROTEIN 2;

EID: 84856731262     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2011.11.030     Document Type: Article

References (61)

1. Ben-Barak Y., Russell J.T., Whitnall M.H., Ozato K., Gainer H. Neurophysin in the hypothalamo-neurohypophysial system. I. Production and characterization of monoclonal antibodies. J.Neurosci. 1985, 5:81-97.
2. Bosch O.J., Meddle S.L., Beiderbeck D.I., Douglas A.J., Neumann I.D. Brain oxytocin correlates with maternal aggression: link to anxiety. J.Neurosci. 2005, 25:6807-6815.
3. Boyden E.S., Zhang F., Bamberg E., Nagel G., Deisseroth K. Millisecond-timescale, genetically targeted optical control of neural activity. Nat. Neurosci. 2005, 8:1263-1268.
4. Brownstein M.J., Russell J.T., Gainer H. Synthesis, transport, and release of posterior pituitary hormones. Science 1980, 207:373-378.
5. Buijs R.M. Vasopressin and oxytocin-their role in neurotransmission. Pharmacol. Ther. 1983, 22:127-141.
6. Burbach J.P.H., Luckman S.M., Murphy D., Gainer H. Gene regulation in the magnocellular hypothalamo-neurohypophysial system. Physiol. Rev. 2001, 81:1197-1267.
7. Caldwell J.D., Greer E.R., Johnson M.F., Prange A.J., Pedersen C.A. Oxytocin and vasopressin immunoreactivity in hypothalamic and extrahypothalamic sites in late pregnant and postpartum rats. Neuroendocrinology 1987, 46:39-47.
8. Cetin A., Komai S., Eliava M., Seeburg P.H., Osten P. Stereotaxic gene delivery in the rodent brain. Nat. Protoc. 2006, 1:3166-3173.
9. Ciocchi S., Herry C., Grenier F., Wolff S.B., Letzkus J.J., Vlachos I., Ehrlich I., Sprengel R., Deisseroth K., Stadler M.B., et al. Encoding of conditioned fear in central amygdala inhibitory circuits. Nature 2010, 468:277-282.
10. Davis M. A functional analysis. The Amygdala 2000, 213-288. Oxford University Press, New York. J.P. Aggleton (Ed.).
11. De Dreu C.K.W., Greer L.L., Handgraaf M.J.J., Shalvi S., Van Kleef G.A., Baas M., Ten Velden F.S., Van Dijk E., Feith S.W.W. The neuropeptide oxytocin regulates parochial altruism in intergroup conflict among humans. Science 2010, 328:1408-1411.
12. Dittgen T., Nimmerjahn A., Komai S., Licznerski P., Waters J., Margrie T.W., Helmchen F., Denk W., Brecht M., Osten P. Lentivirus-based genetic manipulations of cortical neurons and their optical and electrophysiological monitoring invivo. Proc. Natl. Acad. Sci. USA 2004, 101:18206-18211.
13. Donaldson Z.R., Young L.J. Oxytocin, vasopressin, and the neurogenetics of sociality. Science 2008, 322:900-904.
14. Eliava M., Yilmazer-Hanke D., Asan E. Interrelations between monoaminergic afferents and corticotropin-releasing factor-immunoreactive neurons in the rat central amygdaloid nucleus: ultrastructural evidence for dopaminergic control of amygdaloid stress systems. Histochem. Cell Biol. 2003, 120:183-197.
15. Ferris C.F., Foote K.B., Meltser H.M., Plenby M.G., Smith K.L., Insel T.R. Oxytocin in the amygdala facilitates maternal aggression. Ann. N Y Acad. Sci. 1992, 652:456-457.
16. Gimpl G., Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol. Rev. 2001, 81:629-683.
17. Griffin G.D., Ferri-Kolwicz S.L., Reyes B.A.S., Van Bockstaele E.J., Flanagan-Cato L.M. Ovarian hormone-induced reorganization of oxytocin-labeled dendrites and synapses lateral to the hypothalamic ventromedial nucleus in female rats. J.Comp. Neurol. 2010, 518:4531-4545.
18. Grinevich V., Brecht M., Osten P. Monosynaptic pathway from rat vibrissa motor cortex to facial motor neurons revealed by lentivirus-based axonal tracing. J.Neurosci. 2005, 25:8250-8258.
19. Haubensak W., Kunwar P.S., Cai H., Ciocchi S., Wall N.R., Ponnusamy R., Biag J., Dong H.W., Deisseroth K., Callaway E.M., et al. Genetic dissection of an amygdala microcircuit that gates conditioned fear. Nature 2010, 468:270-276.
20. Hitchcock J.M., Davis M. Efferent pathway of the amygdala involved in conditioned fear as measured with the fear-potentiated startle paradigm. Behav. Neurosci. 1991, 105:826-842.
21. Hökfelt T. Neuropeptides in perspective: the last ten years. Neuron 1991, 7:867-879.
22. Huber D., Veinante P., Stoop R. Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science 2005, 308:245-248.
23. Kapp B.S., Frysinger R.C., Gallagher M., Haselton J.R. Amygdala central nucleus lesions: effect on heart rate conditioning in the rabbit. Physiol. Behav. 1979, 23:1109-1117.
24. Kawasaki A., Hoshi K., Kawano M., Nogami H., Yoshikawa H., Hisano S. Up-regulation of VGLUT2 expression in hypothalamic-neurohypophysial neurons of the rat following osmotic challenge. Eur. J. Neurosci. 2005, 22:672-680.
25. Krause E.G., de Kloet A.D., Flak J.N., Smeltzer M.D., Solomon M.B., Evanson N.K., Woods S.C., Sakai R.R., Herman J.P. Hydration state controls stress responsiveness and social behavior. J.Neurosci. 2011, 31:5470-5476.
26. Landgraf R., Neumann I.D. Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication. Front. Neuroendocrinol. 2004, 25:150-176.
27. Lee H.-J., Macbeth A.H., Pagani J.H., Young W.S. Oxytocin: the great facilitator of life. Prog. Neurobiol. 2009, 88:127-151.
28. Liposits Z., Sherman D., Phelix C., Paull W.K. A combined light and electron microscopic immunocytochemical method for the simultaneous localization of multiple tissue antigens. Tyrosine hydroxylase immunoreactive innervation of corticotropin releasing factor synthesizing neurons in the paraventricular nucleus of the rat. Histochemistry 1986, 85:95-106.
29. Lubin D.A., Elliott J.C., Black M.C., Johns J.M. An oxytocin antagonist infused into the central nucleus of the amygdala increases maternal aggressive behavior. Behav. Neurosci. 2003, 117:195-201.
30. Ludwig M., Leng G. Dendritic peptide release and peptide-dependent behaviours. Nat. Rev. Neurosci. 2006, 7:126-136.
31. McEwen B.B. Brain-fluid barriers: relevance for theoretical controversies regarding vasopressin and oxytocin memory research. Adv. Pharmacol. 2004, 50:531-592. 655-708.
32. Meeker R.B., Swanson D.J., Greenwood R.S., Hayward J.N. Ultrastructural distribution of glutamate immunoreactivity within neurosecretory endings and pituicytes of the rat neurohypophysis. Brain Res. 1991, 564:181-193.
33. Nagel G., Szellas T., Huhn W., Kateriya S., Adeishvili N., Berthold P., Ollig D., Hegemann P., Bamberg E. Channelrhodopsin-2, a directly light-gated cation-selective membrane channel. Proc. Natl. Acad. Sci. USA 2003, 100:13940-13945.
34. Navone F., Di Gioia G., Jahn R., Browning M., Greengard P., De Camilli P. Microvesicles of the neurohypophysis are biochemically related to small synaptic vesicles of presynaptic nerve terminals. J. Cell Biol. 1989, 109:3425-3433.
35. Neumann I.D. Stimuli and consequences of dendritic release of oxytocin within the brain. Biochem. Soc. Trans. 2007, 35:1252-1257.
36. Neumann I.D. Brain oxytocin: a key regulator of emotional and social behaviours in both females and males. J.Neuroendocrinol. 2008, 20:858-865.
37. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1998, Academic Press, London. Fourth Edition.
38. Peters J.H., McDougall S.J., Kellett D.O., Jordan D., Llewellyn-Smith I.J., Andresen M.C. Oxytocin enhances cranial visceral afferent synaptic transmission to the solitary tract nucleus. J.Neurosci. 2008, 28:11731-11740.
39. Pilpel N., Landeck N., Klugmann M., Seeburg P.H., Schwarz M.K. Rapid, reproducible transduction of select forebrain regions by targeted recombinant virus injection into the neonatal mouse brain. J.Neurosci. Methods 2009, 182:55-63.
40. Rancz E.A., Franks K.M., Schwarz M.K., Pichler B., Schaefer A.T., Margrie T.W. Transfection via whole-cell recording invivo: bridging single-cell physiology, genetics and connectomics. Nat. Neurosci. 2011, 14:527-532.
41. Roozendaal B., Schoorlemmer G.H., Wiersma A., Sluyter S., Driscoll P., Koolhaas J.M., Bohus B. Opposite effects of central amygdaloid vasopressin and oxytocin on the regulation of conditioned stress responses in male rats. Ann. N Y Acad. Sci. 1992, 652:460-461.
42. Roozendaal B., Wiersma A., Driscoll P., Koolhaas J.M., Bohus B. Vasopressinergic modulation of stress responses in the central amygdala of the Roman high-avoidance and low-avoidance rat. Brain Res. 1992, 596:35-40.
43. Roozendaal B., Schoorlemmer G.H., Koolhaas J.M., Bohus B. Cardiac, neuroendocrine, and behavioral effects of central amygdaloid vasopressinergic and oxytocinergic mechanisms under stress-free conditions in rats. Brain Res. Bull. 1993, 32:573-579.
44. Ross H.E., Young L.J. Oxytocin and the neural mechanisms regulating social cognition and affiliative behavior. Front. Neuroendocrinol. 2009, 30:534-547.
45. Ross H.E., Cole C.D., Smith Y., Neumann I.D., Landgraf R., Murphy A.Z., Young L.J. Characterization of the oxytocin system regulating affiliative behavior in female prairie voles. Neuroscience 2009, 162:892-903.
46. Sawchenko P.E., Swanson L.W. The organization and biochemical specificity of afferent projections to the paraventricular and supraoptic nuclei. Prog. Brain Res. 1983, 60:19-29.
47. Simeon D., Bartz J., Hamilton H., Crystal S., Braun A., Ketay S., Hollander E. Oxytocin administration attenuates stress reactivity in borderline personality disorder: a pilot study. Psychoneuroendocrinology 2011, 36:1418-1421.
48. Skrundz M., Bolten M., Nast I., Hellhammer D.H., Meinlschmidt G. Plasma oxytocin concentration during pregnancy is associated with development of postpartum depression. Neuropsychopharmacology 2011, 36:1886-1893.
49. Sofroniew M.V. Morphology of vasopressin and oxytocin neurones and their central and vascular projections. Prog. Brain Res. 1983, 60:101-114.
50. Swanson L.W., Petrovich G.D. What is the amygdala?. Trends Neurosci. 1998, 21:323-331.
51. Swanson L.W., Sawchenko P.E. Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Annu. Rev. Neurosci. 1983, 6:269-324.
52. Theodosis D.T. Oxytocin-immunoreactive terminals synapse on oxytocin neurones in the supraoptic nucleus. Nature 1985, 313:682-684.
53. Theodosis D.T. Oxytocin-secreting neurons: A physiological model of morphological neuronal and glial plasticity in the adult hypothalamus. Front. Neuroendocrinol. 2002, 23:101-135.
54. Veenema A.H., Neumann I.D. Central vasopressin and oxytocin release: regulation of complex social behaviours. Prog. Brain Res. 2008, 170:261-276.
55. Viviani D., Charlet A., van den Burg E., Robinet C., Hurni N., Abatis M., Magara F., Stoop R. Oxytocin selectively gates fear responses through distinct outputs from the central amygdala. Science 2011, 333:104-107.
56. Wickersham I.R., Lyon D.C., Barnard R.J., Mori T., Finke S., Conzelmann K.K., Young J.A., Callaway E.M. Monosynaptic restriction of transsynaptic tracing from single, genetically targeted neurons. Neuron 2007, 53:639-647.
57. Wickersham I.R., Sullivan H.A., Seung H.S. Production of glycoprotein-deleted rabies viruses for monosynaptic tracing and high-level gene expression in neurons. Nat. Protoc. 2010, 5:595-606.
58. Wilensky A.E., Schafe G.E., Kristensen M.P., LeDoux J.E. Rethinking the fear circuit: the central nucleus of the amygdala is required for the acquisition, consolidation, and expression of Pavlovian fear conditioning. J.Neurosci. 2006, 26:12387-12396.
59. Wotjak C.T., Ganster J., Kohl G., Holsboer F., Landgraf R., Engelman M. Dissociated central and peripheral release of vasopressin, but not oxytocin, in response to repeated swim stress: new insights into the secretory capacities of peptidergic neurons. Neuroscience 1998, 85:1209-1222.
60. Yizhar O., Fenno L.E., Davidson T.J., Mogri M., Deisseroth K. Optogenetics in neural systems. Neuron 2011, 71:9-34.
61. Zingg H.H., Lefebvre D.L. Oxytocin and vasopressin gene expression during gestation and lactation. Brain Res. 1988, 464:1-6.